FDA.reportPublic FDA data

Octagam 2 GM per 20 ML Injection

RxCUI
1809499
RxNorm name
Octagam 2 GM per 20 ML Injection
Display name
Octagam 2 GM per 20 ML Injection
Full name
Octagam 2 GM per 20 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125062OctagamImmune Globulin Intravenous (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a36a12dc-16be-b135-466f-393954f428a7octagam 10 % in 20 ML Injection [PSN] · 20 ML immunoglobulin G, human 100 MG/ML Injection [Octagam] [SBD] · 20 ML Octagam 100 MG/ML Injection [SY] · Octagam 10 % per 20 ML Injection [SY] · Octagam 2 GM per 20 ML Injection [SY]521These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 201420220408
eb4c342b-122c-0072-1428-1747882e6c00octagam 10 % in 20 ML Injection [PSN] · 20 ML immunoglobulin G, human 100 MG/ML Injection [Octagam] [SBD] · 20 ML Octagam 100 MG/ML Injection [SY] · Octagam 10 % per 20 ML Injection [SY] · Octagam 2 GM per 20 ML Injection [SY]52These highlights do not include all the information needed to use Octagam 10% safely and effectively. See full prescribing information for Octagam 10%. Octagam 10% [Immune Globulin Intravenous (Human)] liquid solution for intravenous administration Initial U.S. Approval: 201420240126